For example, having a weaker complement regulation system due to factor H or membrane cofactor protein (MCP) pathogenic variants predisposes to atypical hemolytic uremic syndrome (HUS), but is insufficient to trigger the disease itself. This evidence concerns the gene CD46 and hemolytic-uremic syndrome.